Literature DB >> 22634614

Bacterial RNA mediates activation of caspase-1 and IL-1β release independently of TLRs 3, 7, 9 and TRIF but is dependent on UNC93B.

Tatjana Eigenbrod1, Luigi Franchi, Raul Muñoz-Planillo, Carsten J Kirschning, Marina A Freudenberg, Gabriel Núñez, Alexander Dalpke.   

Abstract

Recognition of foreign nucleic acids is important for the induction of an innate immune response against invading pathogens. Although the pathways involved in sensing bacterial DNA and viral RNA are now well established, only limited knowledge is available on mechanisms underlying recognition of bacterial RNA. It has been reported that intracellular delivery of Escherichia coli RNA activates the Nlrp3 inflammasome, but whether this is a general property of bacterial RNA remains unclear as are the pathways involved in pro-IL-1β induction and caspase-1 activation by bacterial RNA. In this study, we report that bacterial RNA from both Gram-positive and Gram-negative bacteria induces activation of caspase-1 and secretion of IL-1β by murine dendritic cells and bone-marrow derived macrophages. Stimulation was independent of the presence of 5'-triphosphate termini and occurred with whole RNA preparations from bacteria but not from eukaryotes. Induction of pro-IL-1β as well as the priming for caspase-1 activation by bacterial RNA was dependent on UNC93B, an endoplasmic reticulum protein essential for delivery of TLRs to the endosome, whereas the established nucleic acid sensing endosomal TLRs 3, 7, and 9 were dispensable. Additionally, caspase-1 activation and IL-1β production by transfected bacterial RNA were absent in MyD88-deficient cells but independent of TRIF. Thus, our data indicate the presence of a yet unidentified intracellular nucleic acid receptor involved in bacterial RNA-induced inflammasome activation and release of IL-1β.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22634614      PMCID: PMC4327882          DOI: 10.4049/jimmunol.1103258

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

2.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

Authors:  O Takeuchi; K Hoshino; T Kawai; H Sanjo; H Takada; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

3.  Cutting edge: innate immune system discriminates between RNA containing bacterial versus eukaryotic structural features that prime for high-level IL-12 secretion by dendritic cells.

Authors:  Gary K Koski; Katalin Karikó; Shuwen Xu; Drew Weissman; Peter A Cohen; Brian J Czerniecki
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

4.  Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.

Authors:  Katalin Karikó; Michael Buckstein; Houping Ni; Drew Weissman
Journal:  Immunity       Date:  2005-08       Impact factor: 31.745

5.  A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes.

Authors:  N A Thornberry; H G Bull; J R Calaycay; K T Chapman; A D Howard; M J Kostura; D K Miller; S M Molineaux; J R Weidner; J Aunins
Journal:  Nature       Date:  1992-04-30       Impact factor: 49.962

6.  Distribution of 5'-triphosphate termini on the mRNA of Escherichia coli.

Authors:  C D Bieger; D P Nierlich
Journal:  J Bacteriol       Date:  1989-01       Impact factor: 3.490

7.  Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.

Authors:  Masahiro Yamamoto; Shintaro Sato; Hiroaki Hemmi; Katsuaki Hoshino; Tsuneyasu Kaisho; Hideki Sanjo; Osamu Takeuchi; Masanaka Sugiyama; Masaru Okabe; Kiyoshi Takeda; Shizuo Akira
Journal:  Science       Date:  2003-07-10       Impact factor: 47.728

8.  Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.

Authors:  K Hoebe; X Du; P Georgel; E Janssen; K Tabeta; S O Kim; J Goode; P Lin; N Mann; S Mudd; K Crozat; S Sovath; J Han; B Beutler
Journal:  Nature       Date:  2003-07-20       Impact factor: 49.962

9.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function.

Authors:  O Adachi; T Kawai; K Takeda; M Matsumoto; H Tsutsui; M Sakagami; K Nakanishi; S Akira
Journal:  Immunity       Date:  1998-07       Impact factor: 31.745

10.  Recognition of single-stranded RNA viruses by Toll-like receptor 7.

Authors:  Jennifer M Lund; Lena Alexopoulou; Ayuko Sato; Margaret Karow; Niels C Adams; Nicholas W Gale; Akiko Iwasaki; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205

View more
  18 in total

Review 1.  Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors.

Authors:  Surya Pandey; Taro Kawai; Shizuo Akira
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-10-09       Impact factor: 10.005

2.  Caspase-11 interaction with NLRP3 potentiates the noncanonical activation of the NLRP3 inflammasome.

Authors:  Julien Moretti; Baosen Jia; Zachary Hutchins; Soumit Roy; Hilary Yip; Jiahui Wu; Meimei Shan; Samie R Jaffrey; Jörn Coers; J Magarian Blander
Journal:  Nat Immunol       Date:  2022-04-29       Impact factor: 31.250

Review 3.  Inflammasome Activation Can Mediate Tissue-Specific Pathogenesis or Protection in Staphylococcus aureus Infection.

Authors:  Jason H Melehani; Joseph A Duncan
Journal:  Curr Top Microbiol Immunol       Date:  2016       Impact factor: 4.291

4.  The DHX33 RNA helicase senses cytosolic RNA and activates the NLRP3 inflammasome.

Authors:  Hiroki Mitoma; Shino Hanabuchi; Taeil Kim; Musheng Bao; Zhiqiang Zhang; Naoshi Sugimoto; Yong-Jun Liu
Journal:  Immunity       Date:  2013-07-18       Impact factor: 31.745

5.  RNA and β-hemolysin of group B Streptococcus induce interleukin-1β (IL-1β) by activating NLRP3 inflammasomes in mouse macrophages.

Authors:  Rahul Gupta; Shubhendu Ghosh; Brian Monks; Rosane B DeOliveira; Te-Chen Tzeng; Parisa Kalantari; Anubhab Nandy; Bornali Bhattacharjee; Jennie Chan; Fabianno Ferreira; Vijay Rathinam; Shruti Sharma; Egil Lien; Neal Silverman; Katherine Fitzgerald; Arnaud Firon; Patrick Trieu-Cuot; Philipp Henneke; Douglas T Golenbock
Journal:  J Biol Chem       Date:  2014-04-01       Impact factor: 5.157

Review 6.  The role of innate immune signals in immunity to Brucella abortus.

Authors:  Marco Túlio R Gomes; Priscila C Campos; Leonardo A de Almeida; Fernanda S Oliveira; Miriam Maria S Costa; Fernanda M Marim; Guilherme S M Pereira; Sergio C Oliveira
Journal:  Front Cell Infect Microbiol       Date:  2012-10-25       Impact factor: 5.293

Review 7.  Inflammasome/IL-1β Responses to Streptococcal Pathogens.

Authors:  Christopher N LaRock; Victor Nizet
Journal:  Front Immunol       Date:  2015-10-08       Impact factor: 7.561

8.  Respiratory syncytial virus (RSV) infection in elderly mice results in altered antiviral gene expression and enhanced pathology.

Authors:  Terianne M Wong; Sandhya Boyapalle; Viviana Sampayo; Huy D Nguyen; Raminder Bedi; Siddharth G Kamath; Martin L Moore; Subhra Mohapatra; Shyam S Mohapatra
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

9.  Nod-like receptor protein 3 inflammasome activation by Escherichia coli RNA induces transforming growth factor beta 1 secretion in hepatic stellate cells.

Authors:  Hui Wang; Shu Liu; Ying Wang; Bing Chang; Bingyuan Wang
Journal:  Bosn J Basic Med Sci       Date:  2016-01-14       Impact factor: 3.363

10.  Toll-Like Receptor 3/TRIF-Dependent IL-12p70 Secretion Mediated by Streptococcus pneumoniae RNA and Its Priming by Influenza A Virus Coinfection in Human Dendritic Cells.

Authors:  Laura Spelmink; Vicky Sender; Karina Hentrich; Thomas Kuri; Laura Plant; Birgitta Henriques-Normark
Journal:  MBio       Date:  2016-03-08       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.